Drug Type Small molecule drug |
Synonyms WCK-2664 |
Target |
Action inhibitors |
Mechanism 50S subunit inhibitors(50S ribosomal subunit inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H22FN7O3 |
InChIKeyWLOMQLFLRIRYOX-HNNXBMFYSA-N |
CAS Registry928156-92-7 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Bacterial Infections | Preclinical | India | 01 Sep 2019 |





